Skip to main content

Media Coverage

Media Coverage

How Marc Benioff paired experts in AI and prostate cancer, leading to a new way to fine-tune treatments

The company was formed in September 2021 and two years later lined up $90 million.

Read more

Media Coverage

Across the Prostate Cancer Continuum: Translating ArteraAI’s Biopsy Model in Localized Disease and Beyond

Since launching the ArteraAI Prostate Test, Artera has used multimodal artificial intelligence (MMAI) algorithms to help thou [...]

Read more

Media Coverage

FDA just signed off on AI predicting long-term cancer outcomes

The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be effecti [...]

Read more

Media Coverage

FDA Okays AI-Based Prostate Cancer Risk-Stratification Tool

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artific [...]

Read more

Media Coverage

Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment

Identifying men with high-risk, non-metastatic prostate cancer who will truly benefit from intensified treatment from therape [...]

Read more

Media Coverage

AI Tool Accurately Predicts Prostate Cancer Outcomes Across Racial Groups

Mack Roach III, MD, professor of radiation oncology, medical oncology, and urology at the University of California, San Franc [...]

Read more

Media Coverage

Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

The study evaluated the performance of a multimodal artificial intelligence model to close gaps in care and validate that AI [...]

Read more

Media Coverage

Artera Bullish on Prostate Cancer Test Following NYS Approval, Impending Registry Study

NEW YORK – Startup firm Artera is continuing to make commercial progress with its artificial intelligence-based prostate canc [...]

Read more

Media Coverage

How AI Is Helping Cancer Patients: Saving Lives And Money

Cancer treatment is costly. The average cost of cancer care in the U.S. is around $150,000 per patient—more than four times t [...]

Read more

1 2 3 6